• Fundamentals of Solid Formulation

    2nd Edition

    • April 7, 14, 21, 28, May 5, 12, 19

    • 11:00 AM – Noon EDT

For busy professionals working in pharmaceutical solid form, we have created a 7-week webinar series to distill state-of-the-art solutions to key challenges. Each webinar will feature a leading expert who understands your daily workflow and will share his/her real-world experience in successfully supporting preclinical and clinical projects. The series will catalyze discussions aimed at ensuring a stable form is selected with optimal bioavailability and manufacturing properties.


  • Correlation of Drug Substance Bulk Properties to Predict and Troubleshoot the Formulation of Drug Product

    • April 7

    • 11:00 AM – Noon EDT

    Henry Morrison PhD

    Senior Research Scientist II, Gilead Sciences, United States

  • Importance of Solid Form in Formulation and Bioavailability during Research and Development

    • April 14

    • 11:00 AM – Noon EDT

    Sudhakar Garad PhD

    Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, United States

  • Solid State Modeling and Its Role in Drug Development

    • April 21

    • 11:00 AM – Noon EDT

    Luca Iuzzolino PhD

    Computational Research Scientist, Merck, United States

  • Amorphous Formulations for Solubility Enhancement: Risks and Opportunities

    • April 28

    • 11:00 AM – Noon EDT

    Daniel Joseph Price PhD

    Strategic Marketing Manager, Millipore Sigma, Germany

  • Current Practice and Future Perspective in Crystallography for API Solid Form Risk-Management

    • May 5

    • 11:00 AM – Noon EDT

    Luca Russo PhD

    GSK Fellow, GlaxoSmithKline, United Kingdom

  • Application of 15N SSNMR to Differentiate and Quantify Different API Amorphous Phases in Complex Tablet Formulation

    • May 12

    • 11:00 AM – Noon EDT

    Ales Medek PhD

    Research Fellow, Vertex, United States

  • Crystallisation in Agrochemicals: The Good, the Bad, and the Unusual

    • May 19

    • 11:00 AM – Noon EDT

    Adam Keates PhD

    Specialist Particle Scientist, Syngenta, United Kingdom